Stock analysts at Leerink Partnrs reduced their FY2024 EPS estimates for shares of United Therapeutics in a research note issued on Tuesday, February 11th. Leerink Partnrs analyst R. Ruiz now expects ...
Chinese stocks are surging as US markets struggle under President Donald Trump’s economic policies. The Hang Seng China ...
We recently published a list of 10 Worst Performing Bank Stocks in 2024. In this article, we are going to take a look at ...
We recently published a list of 10 Worst Performing Bank Stocks in 2024. In this article, we are going to take a look at ...
The Bank of England needs to move cautiously with cutting interest rates because the long process of wrestling down inflation ...
Some companies around the world are not just stiffening their office mandates but including them in performance metrics.
Goldman Sachs will no longer bar companies with all White boards from receiving IPO services as business after business drops ...
A weak vaccine result dragged on CSL's H1 result but analysts focus on an improving plasma product margin and solid growth forecasts in maintaining positive views ...
US President Donald Trump has threatened to open new fronts in his tariffs war by announcing reciprocal levies on other ...
Nonetheless, if the private sector begins to invest and innovate, it could enhance income and employment opportunities, ...
Goldman expects ONON to deliver a 22 percent compounded annual growth rate (CAGR) from 2024 to 2028, with EBIT margins improving 360 basis points to 12.3 percent of sales, driven by direct-to-consumer ...
The Dow Jones Industrial Average gets outsize attention, presenting a distorted picture of what’s going on with stocks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results